Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Logan Paul's energy drink has 'so much caffeine in it that it puts Red Bull to shame,' declares US senator in call for FDA investigation

Prime, Paul’s energy drink advertised to kids, is raising eyebrows for its health content.

PC Gamer

FDA asked to investigate Prime drink

Senator Chuck Schumer has asked the administrative body to look into the high caffeine levels of Prime

Salon

The FDA is being asked to look into Logan Paul’s energy drink, which has the caffeine of 6 Coke cans

The influencer-backed energy drink Prime is popular among children but lawmakers and health experts are concerned over its potentially dangerous levels of caffeine.

Chicago Sun-Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Prime drink's alarming caffeine content like 6 cans of Coke as politician demands probe

US Senate Majority Leader Chuck Schumer has demanded KSI and Logan Paul's 'PRIME' energy drink is investigated as it contains twice the amount of caffeine found in Red Bull

Daily Mirror

Retailers seek to shake up clinical trials business

Big retailers see a growth opportunity tapping their huge customer bases to recruit participants into clinical trials.

Axios

Prime energy drink could be probed by FDA over high caffeine claims

The FDA is being asked to look into Logan Paul and KSI’s energy drink, which has the caffeine of 6 Coke cans

Evening Standard

Logan Paul’s energy drink with the caffeine of six Coke cans faces calls for FDA probe

An influencer-backed energy drink that has earned viral popularity among children is facing scrutiny from lawmakers and health experts over its potentially dangerous levels of caffeine

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

The FDA is being asked to look into Logan Paul's energy drink, which has the caffeine of 6 Coke cans

An influencer-backed energy drink that has earned viral popularity among children is facing scrutiny from lawmakers and health experts over its potentially dangerous levels of caffeine

The Independent UK

Tennessee Ban on Sexual-Identity-Related Medical Procedures for Minors Is Likely Constitutional,

a Sixth Circuit panel concludes (by a 2-1 vote) in staying an injunction against the law pending appeal.

Reason

F.D. Flam: Cancer risk or no, diet soda is bad for you

There were good reasons to avoid products with the artificial sweetener aspartame even before the World Health Organization classified it as a “possible carcinogen” last month. But now diet soda drinkers might really want to put down the can.

Tribune News Service

Bryan Johnson admits he saw 'no benefits’ after injecting his son’s plasma

Johnson underwent “the world’s first multigenerational plasma exchange" with his son and father, despite warnings against it.

Fortune

FDA Approves Biogen’s Alzheimer’s Drug That Slows Down Cognitive Decline

The FDA fully approved Biogen Inc. but there are other companies with treatments in the pipeline

Zenger

Up First Briefing: Alzheimer's drug; Ukraine cluster bombs; tap water chemicals

The FDA approved the first drug shown to slow down Alzheimer's. The Biden administration will send controversial cluster bombs to Ukraine. A study estimates PFAS is in nearly half of U.S. tap water.

WEKU

Miracle new Alzheimer's drug which slows cognitive decline of disease to be rolled out

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia

Daily Mirror

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

FDA fully approves new Alzheimer’s drug to slow down disease progression

‘Today’s action is first verification that a drug targeting underlying disease process has shown clinical benefit’

Salon

FDA approves new Alzheimer's drug

Leqembi has proven to slow the progression of the disease, while others only target its symptoms

Al Jazeera

US government approves Alzheimer’s drug to slow cognitive decline

Some insurances, including the government-run Medicare, refused to pay for the drug until it received full approval.

Tribune News Service

Eisai Alzheimer's drug gets full US approval, widening access to the therapy

Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from U.S. regulators Thursday, a move expected to widen access to the first drug cleared based on its ability to slow progression of the mind-robbing disease.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall With Jobs Report Due; Meta Leads 7 Resilient Stocks

The jobs report looms with Treasury yields soaring. Meta is among stocks holding up as Threads had record first-day downloads.

Axios

FDA approves Leqembi, first drug to slow Alzheimer’s progression

Eisai and Biogen's Leqembi is the first drug to slow Alzheimer's progression to receive full FDA approval.

The Independent UK

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease

WEKU

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

Roll Call

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Daily Mirror

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

Investors Business Daily

Biogen Skids As Analysts Debate Uptake For Newly Approved Alzheimer's Drug

Biogen stock skidded Friday after the Food and Drug Administration fully approved its Alzheimer's treatment, Leqembi.

1 … 63 64 65 66

People

Chiquita BrooksLaSure

14 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations